Diplotyper: Diplotype-based association analysis

BMC Medical Genomics

Volumn 6, Issue SUPPL2, 2013, Pages

  Kim, Sunshin ^a   Park, Kyungchae ^a   Shin, Chol ^b   Cho, Nam H ^c   Ko, Jeong Jae ^a   Koh, Insong ^d   Kwack, Kyubum ^a  

^a CHA University   (South Korea)

^b Korea University College of Medicine   (South Korea)

^c Ajou University School of Medicine   (South Korea)

^d Hanyang University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIVER TRIACYLGLYCEROL LIPASE;

ADULT; ALGORITHM; ARTICLE; CLUSTER ANALYSIS; DIPLOTYPE BASED ASSOCIATION ANALYSIS; DIPLOTYPER; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HEPATIC LIPASE GENE; HUMAN; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ALGORITHMS; CHOLESTEROL, HDL; CROSS-SECTIONAL STUDIES; FEMALE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; LIPASE; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; SOFTWARE;

EID: 84877359686     PISSN: None     EISSN: 17558794     Source Type: Journal    
DOI: 10.1186/1755-8794-6-S2-S5     Document Type: Article

References (34)

1. A haplotype map of the human genome. Nature 2005 437 7063 1299 1320 10.1038/nature04226 16255080 (Pubitemid 41568671)
2. Haploview: analysis and visualization of LD and haplotype maps. Barrett JC, Fry B, Maller J, Daly MJ, Bioinformatics 2005 21 2 263 265 10.1093/bioinformatics/bth457 15297300 (Pubitemid 40202029)
3. PLINK: a tool set for whole-genome association and population-based linkage analyses. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, et al. Am J Hum Genet 2007 81 3 559 575 10.1086/519795 17701901 (Pubitemid 47330214)
4. Partition-ligation-expectation-maximization algorithm for haplotype inference with single-nucleotide polymorphisms. Qin ZS, Niu T, Liu JS, Am J Hum Genet 2002 71 5 1242 1247 10.1086/344207 12452179 (Pubitemid 35305248)
5. WHAP: haplotype-based association analysis. Purcell S, Daly MJ, Sham PC, Bioinformatics 2007 23 2 255 256 10.1093/bioinformatics/btl580 17118959 (Pubitemid 46189621)
6. A new JAVA interface implementation of THESIAS: testing haplotype effects in association studies. Tregouet DA, Garelle V, Bioinformatics 2007 23 8 1038 1039 10.1093/bioinformatics/btm058 17308338 (Pubitemid 47050595)
7. Ancient haplotypes of the HLA Class II region. Raymond CK, Kas A, Paddock M, Qiu R, Zhou Y, Subramanian S, Chang J, Palmieri A, Haugen E, Kaul R, et al. Genome Res 2005 15 9 1250 1257 10.1101/gr.3554305 16140993 (Pubitemid 41247915)
8. A survey of haplotype variants at several disease candidate genes: the importance of rare variants for complex diseases. Liu PY, Zhang YY, Lu Y, Long JR, Shen H, Zhao LJ, Xu FH, Xiao P, Xiong DH, Liu YJ, et al. J Med Genet 2005 42 3 221 227 10.1136/jmg.2004.024752 15744035 (Pubitemid 40380302)
9. HLA-G regulatory haplotypes and implantation outcome in couples who underwent assisted reproduction treatment. Costa CH, Gelmini GF, Wowk PF, Mattar SB, Vargas RG, Roxo VM, Schuffner A, da Graca Bicalho M, Hum Immunol 2012 73 891 897 10.1016/j.humimm.2012.06.002 22732090
10. Linkage disequilibrium mapping via cladistic analysis of single-nucleotide polymorphism haplotypes. Durrant C, Zondervan KT, Cardon LR, Hunt S, Deloukas P, Morris AP, Am J Hum Genet 2004 75 1 35 43 10.1086/422174 15148658 (Pubitemid 38801899)
11. Diplotype trend regression analysis of the ADH gene cluster and the ALDH2 gene: multiple significant associations with alcohol dependence. Luo X, Kranzler HR, Zuo L, Wang S, Schork NJ, Gelernter J, Am J Hum Genet 2006 78 6 973 987 10.1086/504113 16685648 (Pubitemid 43787689)
12. Hepatic lipase: a pro- or anti-atherogenic protein? Jansen H, Verhoeven AJ, Sijbrands EJ, J Lipid Res 2002 43 9 1352 1362 10.1194/jlr.R200008-JLR200 12235167
13. High-density lipoprotein as a therapeutic target: a systematic review. Singh IM, Shishehbor MH, Ansell BJ, JAMA 2007 298 7 786 798 10.1001/jama.298.7. 786 17699012 (Pubitemid 47263161)
14. Hepatic lipase: a marker for cardiovascular disease risk and response to therapy. Zambon A, Deeb SS, Pauletto P, Crepaldi G, Brunzell JD, Curr Opin Lipidol 2003 14 2 179 189 10.1097/00041433-200304000-00010 12642787 (Pubitemid 36521189)
15. High density lipoprotein cholesterol as a predictor of cardiovascular disease mortality in men and women: the follow-up study of the Lipid Research Clinics Prevalence Study. Jacobs DR Jr, Mebane IL, Bangdiwala SI, Criqui MH, Tyroler HA, Am J Epidemiol 1990 131 1 32 47 2293751 (Pubitemid 20014697)
16. Alterations in plasma and tissue lipids associated with obesity and metabolic syndrome. Aguilera CM, Gil-Campos M, Canete R, Gil A, Clin Sci (Lond) 2008 114 3 183 193 10.1042/CS20070115 (Pubitemid 351293994)
17. HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. Barter P, Gotto AM, LaRosa JC, Maroni J, Szarek M, Grundy SM, Kastelein JJ, Bittner V, Fruchart JC, N Engl J Med 2007 357 13 1301 1310 10.1056/NEJMoa064278 17898099 (Pubitemid 47481452)
18. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Gordon DJ, Probstfield JL, Garrison RJ, Neaton JD, Castelli WP, Knoke JD, Jacobs DR Jr, Bangdiwala S, Tyroler HA, Circulation 1989 79 1 8 15 10.1161/01.CIR.79.1.8 2642759 (Pubitemid 19043669)
19. Inhibition of CETP activity by torcetrapib reduces susceptibility to diet-induced atherosclerosis in New Zealand White rabbits. Morehouse LA, Sugarman ED, Bourassa PA, Sand TM, Zimetti F, Gao F, Rothblat GH, Milici AJ, J Lipid Res 2007 48 6 1263 1272 10.1194/jlr.M600332-JLR200 17325387 (Pubitemid 47312028)
20. Long-term stable expression of human apolipoprotein A-I mediated by helper-dependent adenovirus gene transfer inhibits atherosclerosis progression and remodels atherosclerotic plaques in a mouse model of familial hypercholesterolemia. Belalcazar LM, Merched A, Carr B, Oka K, Chen KH, Pastore L, Beaudet A, Chan L, Circulation 2003 107 21 2726 2732 10.1161/01.CIR. 0000066913.69844.B2 12742997 (Pubitemid 36667248)
21. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Munster (PROCAM) study. Assmann G, Cullen P, Schulte H, Circulation 2002 105 3 310 315 10.1161/hc0302.102575 11804985 (Pubitemid 34106178)
22. The Fourth Korea National Health and Nutrition Examination Survey (KNHANES IV). Korea Center for Disease Control, 2007
23. A hepatic lipase (LIPC) allele associated with high plasma concentrations of high density lipoprotein cholesterol. Guerra R, Wang J, Grundy SM, Cohen JC, Proc Natl Acad Sci USA 1997 94 9 4532 4537 10.1073/pnas.94.9.4532 9114024 (Pubitemid 27194276)
24. The -250G>A promoter variant in hepatic lipase associates with elevated fasting serum high-density lipoprotein cholesterol modulated by interaction with physical activity in a study of 16,156 Danish subjects. Grarup N, Andreasen CH, Andersen MK, Albrechtsen A, Sandbaek A, Lauritzen T, Borch-Johnsen K, Jorgensen T, Schmitz O, Hansen T, et al. J Clin Endocrinol Metab 2008 93 6 2294 2299 10.1210/jc.2007-2815 18364377 (Pubitemid 351831550)
25. A haplotype map of the human genome. Consortium. TIH, Nature 2005 437 7063 1299 1320 10.1038/nature04226 16255080 (Pubitemid 41568671)
26. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Saxena R, Voight BF, Lyssenko V, Burtt NP, de Bakker PI, Chen H, Roix JJ, Kathiresan S, Hirschhorn JN, Daly MJ, et al. Science 2007 316 5829 1331 1336 17463246 (Pubitemid 46871653)
27. Genome-wide scan identifies variation in MLXIPL associated with plasma triglycerides. Kooner JS, Chambers JC, Aguilar-Salinas CA, Hinds DA, Hyde CL, Warnes GR, Gomez Perez FJ, Frazer KA, Elliott P, Scott J, et al. Nat Genet 2008 40 2 149 151 10.1038/ng.2007.61 18193046 (Pubitemid 351171393)
28. Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. Aulchenko YS, Ripatti S, Lindqvist I, Boomsma D, Heid IM, Pramstaller PP, Penninx BW, Janssens AC, Wilson JF, Spector T, et al. Nat Genet 2009 41 1 47 55 10.1038/ng.269 19060911
29. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Willer CJ, Sanna S, Jackson AU, Scuteri A, Bonnycastle LL, Clarke R, Heath SC, Timpson NJ, Najjar SS, Stringham HM, et al. Nat Genet 2008 40 2 161 169 10.1038/ng.76 18193043 (Pubitemid 351171403)
30. The -514 C->T hepatic lipase promoter region polymorphism and plasma lipids: a meta-analysis. Isaacs A, Sayed-Tabatabaei FA, Njajou OT, Witteman JC, van Duijn CM, J Clin Endocrinol Metab 2004 89 8 3858 3863 10.1210/jc.2004-0188 15292318 (Pubitemid 39071485)
31. The structure of haplotype blocks in the human genome. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M, et al. Science 2002 296 5576 2225 2229 10.1126/science.1069424 12029063 (Pubitemid 34680308)
32. Distribution of recombination crossovers and the origin of haplotype blocks: the interplay of population history, recombination, and mutation. Wang N, Akey JM, Zhang K, Chakraborty R, Jin L, Am J Hum Genet 2002 71 5 1227 1234 10.1086/344398 12384857 (Pubitemid 35305243)
33. A large-scale genome-wide association study of Asian populations uncovers genetic factors influencing eight quantitative traits. Cho YS, Go MJ, Kim YJ, Heo JY, Oh JH, Ban HJ, Yoon D, Lee MH, Kim DJ, Park M, et al. Nat Genet 2009 41 5 527 534 10.1038/ng.357 19396169
34. HapStar: automated haplotype network layout and visualization. Teacher AG, Griffiths DJ, Mol Ecol Resour 2011 11 1 151 153 10.1111/j.1755-0998.2010. 02890.x 21429113